Literature DB >> 3772801

Human coffee drinking: reinforcing and physical dependence producing effects of caffeine.

R R Griffiths, G E Bigelow, I A Liebson.   

Abstract

In a residential research ward coffee drinking was studied in nine volunteer human subjects with histories of heavy coffee drinking. The presence or absence of caffeine in the coffee was manipulated under double-blind conditions by using caffeinated (C) or decaffeinated (D) coffee. When subjects were switched alternately for 10 or more consecutive days between C and D, the daily number of cups consumed tended to be relatively stable. In a different experiment, preference for C vs. D was assessed. After experimenter-scheduled exposures, subjects were given choices between C and D. When subjects were presumably caffeine tolerant/dependent, C was rated as being better liked than D and was reliably preferred to D in choice tests. When subjects were not caffeine tolerant/dependent, C was not reliably preferred to D, nor were there pronounced differences in ratings of liking. Under these conditions, some subjects preferred D to C, citing adverse symptoms (suggesting caffeine toxicity) as reasons for avoiding C. The effects of caffeine withdrawal were studied by abruptly substituting D for C for 10 or more days. This resulted in an orderly withdrawal syndrome, having an onset latency of 19 hr, peaking on days 1 and 2, and decreasing progressively over the next 5 or 6 days. The withdrawal syndrome, which was detected on subject-rated, staff-rated and objective behavioral measures, was characterized by increased headache, sleepiness and laziness and decreased alertness and activeness. The present study demonstrates the reinforcing effects of caffeine in humans and also documents the severity of the caffeine withdrawal syndrome. It is concluded that caffeine has the cardinal features of a prototypic drug of abuse.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3772801

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  29 in total

1.  Low-dose caffeine discrimination and self-reported mood effects in normal volunteers.

Authors:  K Silverman; R R Griffiths
Journal:  J Exp Anal Behav       Date:  1992-01       Impact factor: 2.468

Review 2.  A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features.

Authors:  Laura M Juliano; Roland R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  2004-09-21       Impact factor: 4.530

3.  Effects of caffeine on performance and mood: withdrawal reversal is the most plausible explanation.

Authors:  Jack E James; Peter J Rogers
Journal:  Psychopharmacology (Berl)       Date:  2005-07-02       Impact factor: 4.530

Review 4.  Caffeine use in children: what we know, what we have left to learn, and why we should worry.

Authors:  Jennifer L Temple
Journal:  Neurosci Biobehav Rev       Date:  2009-01-20       Impact factor: 8.989

Review 5.  A review of human drug self-administration procedures.

Authors:  Jermaine D Jones; Sandra D Comer
Journal:  Behav Pharmacol       Date:  2013-09       Impact factor: 2.293

Review 6.  The role of human drug self-administration procedures in the development of medications.

Authors:  S D Comer; J B Ashworth; R W Foltin; C E Johanson; J P Zacny; S L Walsh
Journal:  Drug Alcohol Depend       Date:  2008-04-24       Impact factor: 4.492

7.  [Not Available].

Authors:  E Hackenthal
Journal:  Schmerz       Date:  1990-09       Impact factor: 1.107

Review 8.  Caffeine Use Disorder: A Comprehensive Review and Research Agenda.

Authors:  Steven E Meredith; Laura M Juliano; John R Hughes; Roland R Griffiths
Journal:  J Caffeine Res       Date:  2013-09

9.  Caffeine reversal of sleep deprivation effects on alertness and mood.

Authors:  D Penetar; U McCann; D Thorne; G Kamimori; C Galinski; H Sing; M Thomas; G Belenky
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 10.  Clinical models of decision making in addiction.

Authors:  Mikhail N Koffarnus; Brent A Kaplan
Journal:  Pharmacol Biochem Behav       Date:  2017-08-26       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.